Full Press Release Details
EXTON, Pa. , Oct. 22, 2019 /PRNewswire/ -- (Booths #F44 & #F51)— West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced two innovative product offerings at the 2019 PDA Universe of Pre-Filled Syringes and Injection Devices (PDA PFS). West is launching NovaPure® 3mL Cartridge components, an addition to its NovaPure product line, comprised of plunger and lined seal components, specifically designed for consistent delivery for higher-volume injectable drug delivery systems. The Company also announced that the SmartDose® Gen. II 10mL injector, which enables subcutaneous delivery of a wide range of drug formulation viscosities up to 10mL in volume, is now available for commercialization. These innovations, along with highlights from West's high-value product portfolio, Integrated Solutions Program offering, and latest scientific thought leadership, will be showcased at this year's PDA PFS meeting, held October 22-23 in Gothenburg, Sweden .
"Our customers face a number of demands from increasing regulations and requirements, to evolving patient needs, to an ever-changing healthcare landscape. Our goal is to simplify their journey and work by their side to support them with products, services and solutions. We aim to speed their development and to help ensure a continuous supply to the market of important therapies which drive better patient outcomes," said Karen Flynn, Senior Vice President and Chief Commercial Officer, West. "The launch of our NovaPure 3mL Cartridge components line and the enhancements to our SmartDose platform are the first of many upcoming product launches and updates we'll be announcing in the coming months to address specific issues we know our customers are facing as they work to bring innovative, new injectable medicines to market."
The NovaPure 3mL Cartridge components expand the robust NovaPure product portfolio which currently includes stoppers and syringe plungers. NovaPure components embody West's highest quality standard for components, adhering to scientific, risk-mitigating Quality by Design (QbD) principles resulting in dimensional control and consistency, vision inspection and visible particulate control, and best-in class particle specification. The new components are specifically designed for 3mL cartridges often used in autoinjectors and other drug delivery devices. They incorporate West's premium quality enhancements: Westar® pharmaceutical wash and sterilization, FluroTec® barrier film, and a comprehensive data package, and are an ideal choice for sensitive biologic drugs coming to market.
West developed the SmartDose portfolio of devices to offer patients with chronic health conditions, who require medication injections, a reliable, convenient and easy-to-use method for home-based drug administration. The SmartDose Gen. II 10mL drug delivery system adheres to the patient's body, so patients can remain hands-free during the injection, which may range from minutes to hours. The Company has now completed the development work to enable up to 10mL of medication injection and is ready for commercialization.
The well-established scientific and regulatory expertise of West will be featured in the following educational presentations and poster sessions at the PDA PFS meeting:
Podium Presentations ( Tuesday, October 22, 2019 )
Poster Presentation ( Tuesday, October 22 and Wednesday, October 23, 2019 )
Training Workshop ( Wednesday, October 24 and Thursday, October 25, 2019 )
For more information on West's high-quality packaging technologies and drug delivery solutions, including product demonstrations, please visit booths #F44 and #F51 at the PDA PFS meeting or visit us online at www.westpharma.com .
Trademarks and registered trademarks are the property of West Pharmaceutical Services, Inc. and/or one of its subsidiaries, in the United States and other jurisdictions, unless noted otherwise.
FluroTec® technology is licensed from Daikyo Seiko, Ltd.
About West West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania , and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2018 net sales of $1.7 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world. For more information, visit www.westpharma.com .
SOURCE West Pharmaceutical Services, Inc.